Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
Carolina Liquid Chemistries Alcohol Assay Receives CLIA Moderate Complexity Rating for Abbott ImmTox 270
The ethyl alcohol assay categorization enables moderate complexity laboratories to expand drug screening capabilities on the Abbott analyzer platform.
Flow Cytometry
Latest
New Infrared Dye Antibody Conjugates Enable Expanded Flow Cytometry Panel Design
The infrared dye antibody conjugates aim to expand human phenotyping experiments innovation and make high-parameter flow cytometry more accessible.
Mass Spectrometry
Latest
Shimadzu Launches LCMS-8065XE Triple Quadrupole Mass Spectrometer
New instrument features StreamFocus ionization technology and AI-powered intelligence for enhanced sensitivity and efficiency in clinical laboratories.
Immunoassay
Latest
Lateral Flow Assays Market Projected to Reach $12.1 Billion by 2030
Market growth driven by expanding clinical applications and regulatory innovation, with kits and reagents dominating product segments.
Molecular Diagnostics
Latest
Hitachi High-Tech, ELITech Partner on Automated PCR Testing Platform
The companies plan to create a fully automated PCR testing system for infectious disease diagnosis and treatment monitoring.
Point-of-Care
Latest
New Rapid Test Detects Influenza A, B, and COVID-19 in Single Assay
The CLIA-waived immunoassay delivers results in as fast as 10 minutes and is designed for physician offices, urgent care centers, and decentralized hospital labs.